MICROPORT NEURO2172.HKValuation Analysis

As of Oct 16, 2026, MICROPORT NEURO (2172.HK) trades at a P/E of 22.90x, P/B of 2.36x, P/S of 5.36x, and a dividend yield of 1.74%.
Longitudinal percentile comparison: P/E sits at the 23rd percentile over the trailing 10Y window (vs. 26th percentile over 3Y); P/B sits at the 8th percentile over the trailing 10Y window (vs. 10th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 11th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 63rd percentile within its industry and the 77th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.28%, ranking at the 94th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 15.5 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Of the 3.28% total shareholder yield, 1.74% is paid out as dividends and roughly 1.54% is implied to come from buybacks — both channels are meaningfully in play. MICROPORT NEURO operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.